A
$ Value
$0
Shares
198,413
Price
$0
Filed
Aug 1
Insider
Name
Venker Eric
Title
President & Immunovant CEO
CIK
0001801917
Roles
Officer
Transaction Details
Transaction Date
2025-07-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,660,636
Footnotes
Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of May 20, 2025, which service-vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.
Filing Info
Venker Eric's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | ROIV | M | $770K |
| 2026-04-20 | ROIV | ▼ | $5.9M |
| 2026-04-20 | ROIV | M | $0 |
| 2026-04-07 | IMVT | A | $0 |
| 2026-04-07 | IMVT | A | $0 |
| 2026-04-02 | IMVT | ▼ | $308K |
| 2026-04-02 | IMVT | ▼ | $35K |
| 2026-04-01 | IMVT | M | $5.3M |
| 2026-04-01 | IMVT | D | $8.4M |
| 2026-04-01 | IMVT | M | $0 |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |